bertiedog
Senior Member
- Messages
- 1,738
- Location
- South East England, UK
Does anybody have a link to Dr Light's slides?
Thanks
Pam
Thanks
Pam
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
Yes I agree. My ME started when I was 9 / 10 just as pubescent hormones start to 'do their thing'. The change in gender ratio between prepubescents and post pubescents also confirms that this must be so.
What's the difference in gender ratios for pre and post pubescent?
The forum software will automatically convert any Youtube link and embed the video, but importantly, it won't convert any start time that might exist in your Youtube URL.Mark Davis findings so far.. WOW! Fingers crossed.
@Jonathan Edwards have you had a chance to view this talk at all by Immunologist Mark Davis. It is at 5:14:30 (I think I have copied the URL below at about that time). If people want to skip the wee education session on immune things the meat of what he is doing starts from 5:27:30.
I can't seem to be able to give the link without it opening up like above to embed an empty video! Can anyone kindly help me out. A right click on the video comes up with URL options though.
But why can they not get a supply form Bayer, not being profitable makes no sense then they would stop making it altogether. Why do they still make it at all?
If it was about profit they could simply charge him more then the production cost, if he agreed to pay 2-5x above cost they make profit, he gets drug. Pure capitalism.
@user9876 why would the second manufacturer not have to pay for clinical trials?? Who is going to pay for the elusive trials? I dont understand!
That obviously is the key question.Who is going to pay for the elusive trials?
So the main issue is that Suramin is out of patent and is cheap to produce.
Here are some of them:Does anybody have a link to Dr Light's slides?
So the main issue is that Suramin is out of patent and is cheap to produce.
"A failure of the system".Can anyone recall what Ron said about PACE? I remember thinking, ooh that was good, then forgot 10 seconds later
A bit OT here, but when I heard him talking about this I had to wonder if this is why I cannot handle nutrient products designed boost ATP production. Solving one problem, but creating another.
But actual supply is an issue, as I described, so NIH may well be reluctant to fund a trial on a medicine that there is no additional supply of. Fundraisers obviously sidestep the issue of NIH involvement but are still affected by supply, as well as the level that would need to be raised. I really don't want to be too down on the possibility of Suramin being useful to us but we also need to be realistic in regard to the challenges involved.Wouldn't that make it easier to get funding from NIH (or RFAs, or whatever it's called) or do a fundraiser?